Saturday 7 November 2026 Export ALKS’s income statement to Excel — free account

Alkermes plc

ALKS Healthcare Drug Manufacturers Specialty & Generic

Alkermes plc’s revenue for fiscal 2025 (year ended December 2025) was $1.5 billion, down 5.25% from fiscal 2024.

Revenue: +21.8%
EPS: −80.6%
Free cash flow: +6.78%

Quarter to September 2026, against a year earlier

Operating cash flow growth 3 yrs

45.66 1.12 +2.51%

Follow ALKS

Alert me

Market cap: $7.5B
P/E: 0.0×
Fwd P/E: −85.9×
Dividend yield: —
F-score: 7/9
Altman Z: 5.33
Beneish M: −3.29
Dividend safety: n/a

Overview Business Profile Earnings & Analysis Segments Valuation Filings

Alkermes plc (ALKS) P/E ratio

Alert me on P/E ratio

Alkermes plc has no meaningful P/E ratio: its trailing twelve-month earnings is negative. Over the past ten years it has ranged from 0.0× (November 2026) to 137× (July 2026) — the current reading is the lowest in ten years.

Embed this chart

Code for your page

<iframe src="https://stockrow.com/embed/ALKS/pe-ratio" width="100%" height="360" style="border:0" loading="lazy" title="Alkermes plc P/E ratio, 10 years"></iframe>
<p style="font-size:12px">Source: <a href="https://stockrow.com/ALKS/metrics/pe-ratio">Alkermes plc (ALKS) P/E ratio — stockrow.com</a></p>

Period	P/E ratio	Change
FY2025	19.0×	47.59%
FY2024	12.9×	(3.12%)
FY2023	13.3×	—
FY2022	0.0×	—
FY2021	0.0×	—
FY2020	0.0×	—
FY2019	0.0×	—
FY2018	0.0×	—
FY2017	0.0×	—
FY2016	0.0×	—

Period	P/E ratio	Change
Sep 2026	0.0×	—
Jun 2026	130×	241.98%
Mar 2026	38.0×	99.76%
Dec 2025	19.0×	31.33%
43 more quarters	Free account

Against its own ten years

Low 0.0× High 137×

Ten-year median 0.0×

Current reading's percentile 73

Company	P/E ratio
HIMS Hims & Hers Health, Inc. compare	n/m
ELAN Elanco Animal Health Incorporated compare	n/m
ALKS Alkermes plc	n/m
SUPN Indivior Pharmaceuticals Inc. compare	7.0×
LNTH Lantheus Holdings, Inc. compare	24.3×
LQDA Liquidia Corporation compare	28.4×
AMRX AMNEAL PHARMACEUTICALS, INC. compare	38.2×
RDY Dr. Reddy's Laboratories Ltd compare	45.4×
KNSA Kiniksa Pharmaceuticals International, plc compare	65.9×
Drug Manufacturers Specialty & Generic industry median	20.5×
Healthcare sector median	24.5×
Market median	17.8×

What P/E ratio is

Price to Earnings Ratio shows how much investors pay for each dollar of a company’s annual profit per share.

Stock Price ÷ EPS (Basic) (TTM)

The full definition of P/E ratio →

Alkermes plc (ALKS) P/E ratio

P/E ratio, daily

Annual newest first

Quarterly newest first

Against its own ten years

P/E ratio against peers

What P/E ratio is

More on ALKS

P/E ratio, daily

Annual newest first

Quarterly newest first

Against its own ten years

P/E ratio against peers

What P/E ratio is

More on ALKS

Stockrow Weekly